Theravance Biopharma TBPH Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's other non-current liabilities?
- Theravance Biopharma (TBPH) reported other non-current liabilities of $244K in Q1 2026.
- How has Theravance Biopharma's other non-current liabilities changed year-over-year?
- Theravance Biopharma's other non-current liabilities decreased by 81.0% year-over-year, from $1.29M to $244K.
- What is the long-term trend for Theravance Biopharma's other non-current liabilities?
- Over 5 years (2020 to 2025), Theravance Biopharma's other non-current liabilities has grown at a -29.8% compound annual growth rate (CAGR), from $1.83M to $313K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.